Crinetics Pharmaceuticals, Inc. CRNX

$84.44 -0.02% at last close

Recent SEC Filings

FormDescriptionFiledDocument
8-K 8-K 2026-08-14 View →
4 FORM 4 2026-08-11 View →
10-Q 10-Q 2026-08-03 View →
8-K 8-K 2026-08-03 View →
8-K CURRENT REPORT FILING 2026-07-10 View →
4 FORM 4 2026-07-07 View →
8-K 8-K 2026-07-06 View →
4 FORM 4 2026-06-22 View →
4 FORM 4 2026-06-22 View →
4 FORM 4 2026-06-22 View →
4 FORM 4 2026-06-22 View →
4 FORM 4 2026-06-22 View →
4 FORM 4 2026-06-22 View →
4 FORM 4 2026-06-22 View →
8-K 8-K 2026-06-22 View →
4 FORM 4 2026-06-18 View →
4 FORM 4 2026-06-02 View →
10-Q 10-Q 2026-05-07 View →
8-K 8-K 2026-05-07 View →
DEF 14A DEF 14A 2026-04-29 View →
4 FORM 4 2026-04-10 View →
8-K 8-K 2026-04-10 View →
8-K 8-K 2026-03-23 View →
4 FORM 4 2026-03-18 View →
4 FORM 4 2026-03-18 View →
4 FORM 4 2026-03-18 View →
4 FORM 4 2026-03-13 View →
4 FORM 4 2026-03-04 View →
4 FORM 4 2026-03-04 View →
8-K 8-K 2026-03-03 View →
10-K 10-K 2026-02-26 View →
8-K 8-K 2026-02-26 View →
4 FORM 4 2026-02-25 View →
4 FORM 4 2026-02-25 View →
4 FORM 4 2026-02-25 View →
4 FORM 4 2026-02-25 View →
4 FORM 4 2026-02-25 View →
8-K 8-K 2026-01-26 View →
8-K 8-K 2026-01-13 View →
4 FORM 4 2026-01-07 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$84.44
Market Cap
$8.96 billion
52-Week Range
$25.83 – $84.71
Average Volume
6.58 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.